SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bio Key International Inc. – ‘10-Q’ for 6/30/20 – ‘XML’

On:  Friday, 8/14/20, at 4:51pm ET   ·   For:  6/30/20   ·   Accession #:  1437749-20-18059   ·   File #:  1-13463

Previous ‘10-Q’:  ‘10-Q’ on 6/8/20 for 3/31/20   ·   Next:  ‘10-Q’ on 11/16/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23   ·   3 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/14/20  Bio Key International Inc.        10-Q        6/30/20   78:6.3M                                   RDG Filings/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    629K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Document And Entity Information                     HTML     54K 
13: R2          Condensed Consolidated Balance Sheets (Current      HTML    123K 
                Period Unaudited)                                                
14: R3          Condensed Consolidated Balance Sheets (Current      HTML     29K 
                Period Unaudited) (Parentheticals)                               
15: R4          Condensed Consolidated Statements of Operations     HTML     87K 
                (Unaudited)                                                      
16: R5          Condensed Consolidated Statements of Stockholders'  HTML    111K 
                Equity (Deficit) (Unaudited)                                     
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    162K 
                (Unaudited)                                                      
18: R7          Note 1 - Nature of Business and Basis of            HTML     43K 
                Presentation                                                     
19: R8          Note 2 - Going Concern                              HTML     29K 
20: R9          Note 3 - Revenue From Contracts With Customers      HTML    112K 
21: R10         Note 4 - PistolStar Inc. Acquisition                HTML     64K 
22: R11         Note 5 - Accounts Receivable                        HTML     42K 
23: R12         Note 6 - Share Based Compensation                   HTML     38K 
24: R13         Note 7 - Factoring                                  HTML     42K 
25: R14         Note 8 - Inventory                                  HTML     32K 
26: R15         Note 9 - Resalable Software License Rights          HTML     33K 
27: R16         Note 10 - Investment                                HTML     27K 
28: R17         Note 11 - Related Party Transactions                HTML     32K 
29: R18         Note 12 - Convertible Notes Payable                 HTML     98K 
30: R19         Note 13 - Leases                                    HTML     48K 
31: R20         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     69K 
                ("Eps")                                                          
32: R21         Note 15 - Stockholders' Equity                      HTML     41K 
33: R22         Note 16 - Fair Values of Financial Instruments      HTML     26K 
34: R23         Note 17 - Major Customers and Accounts Receivables  HTML     27K 
35: R24         Note 18 - Payment Protection Program Term Note      HTML     28K 
36: R25         Note 19 - Subsequent Events                         HTML     39K 
37: R26         Significant Accounting Policies (Policies)          HTML     48K 
38: R27         Note 3 - Revenue From Contracts With Customers      HTML     91K 
                (Tables)                                                         
39: R28         Note 4 - PistolStar Inc. Acquisition (Tables)       HTML     59K 
40: R29         Note 5 - Accounts Receivable (Tables)               HTML     38K 
41: R30         Note 6 - Share Based Compensation (Tables)          HTML     37K 
42: R31         Note 7 - Factoring (Tables)                         HTML     58K 
43: R32         Note 8 - Inventory (Tables)                         HTML     31K 
44: R33         Note 12 - Convertible Notes Payable (Tables)        HTML     72K 
45: R34         Note 13 - Leases (Tables)                           HTML     50K 
46: R35         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     68K 
                ("Eps") (Tables)                                                 
47: R36         Note 2 - Going Concern (Details Textual)            HTML     37K 
48: R37         Note 3 - Revenue From Contracts With Customers      HTML     29K 
                (Details Textual)                                                
49: R38         Note 3 - Revenue From Contracts With Customers -    HTML     52K 
                Disaggregation of Revenue (Details)                              
50: R39         Note 4 - PistolStar Inc. Acquisition (Details       HTML     36K 
                Textual)                                                         
51: R40         Note 4 - PistolStar Inc. Acquisition - Assets       HTML     54K 
                Acquired and Liabilities Assumed (Details)                       
52: R41         Note 4 - PistolStar Inc. Acquisition - Assets       HTML     24K 
                Acquired and Liabilities Assumed (Details)                       
                (Parentheticals)                                                 
53: R42         Note 4 - PistolStar Inc. Acquisition -              HTML     29K 
                Finite-lived Intangible Assets Acquired (Details)                
54: R43         Note 4 - PistolStar Inc. Acquisition - Pro Forma    HTML     30K 
                Information (Details)                                            
55: R44         Note 5 - Accounts Receivable (Details Textual)      HTML     40K 
56: R45         Note 5 - Accounts Receivable - Summary of Accounts  HTML     37K 
                Receivable (Details)                                             
57: R46         Note 6 - Share Based Compensation - Expenses for    HTML     27K 
                Continuing Operations (Details)                                  
58: R47         Note 7 - Factoring (Details Textual)                HTML     31K 
59: R48         Note 7 - Factoring - Due From Factor (Details)      HTML     25K 
60: R49         Note 7 - Factoring - Fees (Details)                 HTML     22K 
61: R50         Note 8 - Inventory - Components of Inventory        HTML     28K 
                (Details)                                                        
62: R51         Note 9 - Resalable Software License Rights          HTML     41K 
                (Details Textual)                                                
63: R52         Note 10 - Investment (Details Textual)              HTML     31K 
64: R53         Note 11 - Related Party Transactions (Details       HTML     68K 
                Textual)                                                         
65: R54         Note 12 - Convertible Notes Payable (Details        HTML    161K 
                Textual)                                                         
66: R55         Note 12 - Convertible Notes Payable - Convertible   HTML     59K 
                Notes Payable (Details)                                          
67: R56         Note 13 - Leases - Operating Lease Balance Sheet    HTML     38K 
                Information (Details)                                            
68: R57         Note 13 - Leases - Supplemental Cash Flow           HTML     22K 
                Information Related to Leases (Details)                          
69: R58         Note 13 - Leases - Operating Lease Liability        HTML     35K 
                Maturity (Details)                                               
70: R59         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     37K 
                ("EPS") - Reconciliation of Numerator of Basic and               
                Diluted EPS Calculations (Details)                               
71: R60         Note 14 - Earnings (Loss) Per Share - Common Stock  HTML     36K 
                ("EPS") - Securities Excluded From the Diluted Per               
                Share Calculation (Details)                                      
72: R61         Note 15 - Stockholders' Equity (Details Textual)    HTML    109K 
73: R62         Note 17 - Major Customers and Accounts Receivables  HTML     36K 
                (Details Textual)                                                
74: R63         Note 18 - Payment Protection Program Term Note      HTML     23K 
                (Details Textual)                                                
75: R64         Note 19 - Subsequent Events (Details Textual)       HTML     76K 
77: XML         IDEA XML File -- Filing Summary                      XML    144K 
76: EXCEL       IDEA Workbook of Financial Reports                  XLSX     81K 
 6: EX-101.INS  XBRL Instance -- bkyi-20200630                       XML   1.87M 
 8: EX-101.CAL  XBRL Calculations -- bkyi-20200630_cal               XML    125K 
 9: EX-101.DEF  XBRL Definitions -- bkyi-20200630_def                XML   1.29M 
10: EX-101.LAB  XBRL Labels -- bkyi-20200630_lab                     XML   1.03M 
11: EX-101.PRE  XBRL Presentations -- bkyi-20200630_pre              XML   1.31M 
 7: EX-101.SCH  XBRL Schema -- bkyi-20200630                         XSD    214K 
78: ZIP         XBRL Zipped Folder -- 0001437749-20-018059-xbrl      Zip    159K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.20.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 308 </ContextCount>
<ElementCount> 404 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 78 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 5 </UnitCount>
<MyReports>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 000 - Document - Document And Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-document-and-entity-information </Role>
<ShortName> Document And Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited </Role>
<ShortName> Condensed Consolidated Balance Sheets (Current Period Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals </Role>
<ShortName> Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-condensed-consolidated-statements-of-operations-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Operations (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-condensed-consolidated-statements-of-stockholders-equity-deficit-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 006 - Disclosure - Note 1 - Nature of Business and Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-1-nature-of-business-and-basis-of-presentation </Role>
<ShortName> Note 1 - Nature of Business and Basis of Presentation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 007 - Disclosure - Note 2 - Going Concern </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-2-going-concern </Role>
<ShortName> Note 2 - Going Concern </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 008 - Disclosure - Note 3 - Revenue From Contracts With Customers </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers </Role>
<ShortName> Note 3 - Revenue From Contracts With Customers </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 009 - Disclosure - Note 4 - PistolStar Inc. Acquisition </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition- </Role>
<ShortName> Note 4 - PistolStar Inc. Acquisition </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 010 - Disclosure - Note 5 - Accounts Receivable </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-5-accounts-receivable </Role>
<ShortName> Note 5 - Accounts Receivable </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 011 - Disclosure - Note 6 - Share Based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-6-share-based-compensation </Role>
<ShortName> Note 6 - Share Based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 012 - Disclosure - Note 7 - Factoring </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-7-factoring </Role>
<ShortName> Note 7 - Factoring </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 013 - Disclosure - Note 8 - Inventory </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-8-inventory- </Role>
<ShortName> Note 8 - Inventory </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 014 - Disclosure - Note 9 - Resalable Software License Rights </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-9-resalable-software-license-rights </Role>
<ShortName> Note 9 - Resalable Software License Rights </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 015 - Disclosure - Note 10 - Investment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-10-investment </Role>
<ShortName> Note 10 - Investment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 016 - Disclosure - Note 11 - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-11-related-party-transactions </Role>
<ShortName> Note 11 - Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 017 - Disclosure - Note 12 - Convertible Notes Payable </LongName>
<ReportType> Notes </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable </Role>
<ShortName> Note 12 - Convertible Notes Payable </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 018 - Disclosure - Note 13 - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-13-leases </Role>
<ShortName> Note 13 - Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 019 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps </Role>
<ShortName> Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 020 - Disclosure - Note 15 - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-15-stockholders-equity </Role>
<ShortName> Note 15 - Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 021 - Disclosure - Note 16 - Fair Values of Financial Instruments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-16-fair-values-of-financial-instruments </Role>
<ShortName> Note 16 - Fair Values of Financial Instruments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 022 - Disclosure - Note 17 - Major Customers and Accounts Receivables </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-17-major-customers-and-accounts-receivables </Role>
<ShortName> Note 17 - Major Customers and Accounts Receivables </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 023 - Disclosure - Note 18 - Payment Protection Program Term Note </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-18-payment-protection-program-term-note </Role>
<ShortName> Note 18 - Payment Protection Program Term Note </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 024 - Disclosure - Note 19 - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-19-subsequent-events </Role>
<ShortName> Note 19 - Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 025 - Disclosure - Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-significant-accounting-policies-policies </Role>
<ShortName> Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 026 - Disclosure - Note 3 - Revenue From Contracts With Customers (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers-tables </Role>
<ShortName> Note 3 - Revenue From Contracts With Customers (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 027 - Disclosure - Note 4 - PistolStar Inc. Acquisition (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-tables </Role>
<ShortName> Note 4 - PistolStar Inc. Acquisition (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition- </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 028 - Disclosure - Note 5 - Accounts Receivable (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-5-accounts-receivable-tables </Role>
<ShortName> Note 5 - Accounts Receivable (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-5-accounts-receivable </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 029 - Disclosure - Note 6 - Share Based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-6-share-based-compensation-tables </Role>
<ShortName> Note 6 - Share Based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-6-share-based-compensation </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 030 - Disclosure - Note 7 - Factoring (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-7-factoring-tables </Role>
<ShortName> Note 7 - Factoring (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-7-factoring </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 031 - Disclosure - Note 8 - Inventory (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-8-inventory-tables </Role>
<ShortName> Note 8 - Inventory (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-8-inventory- </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 032 - Disclosure - Note 12 - Convertible Notes Payable (Tables) </LongName>
<ReportType> Notes </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable-tables </Role>
<ShortName> Note 12 - Convertible Notes Payable (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 033 - Disclosure - Note 13 - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-13-leases-tables </Role>
<ShortName> Note 13 - Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-13-leases </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 034 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-tables </Role>
<ShortName> Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 035 - Disclosure - Note 2 - Going Concern (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-2-going-concern-details-textual </Role>
<ShortName> Note 2 - Going Concern (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-2-going-concern </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 036 - Disclosure - Note 3 - Revenue From Contracts With Customers (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers-details-textual </Role>
<ShortName> Note 3 - Revenue From Contracts With Customers (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers-tables </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 037 - Disclosure - Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details </Role>
<ShortName> Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 038 - Disclosure - Note 4 - PistolStar Inc. Acquisition (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-details-textual </Role>
<ShortName> Note 4 - PistolStar Inc. Acquisition (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-tables </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 039 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Assets Acquired and Liabilities Assumed (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details </Role>
<ShortName> Note 4 - PistolStar Inc. Acquisition - Assets Acquired and Liabilities Assumed (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 40 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 040 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Assets Acquired and Liabilities Assumed (Details) (Parentheticals) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-assets-acquired-and-liabilities-assumed-details-parentheticals </Role>
<ShortName> Note 4 - PistolStar Inc. Acquisition - Assets Acquired and Liabilities Assumed (Details) (Parentheticals) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 41 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 041 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Finite-lived Intangible Assets Acquired (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-finitelived-intangible-assets-acquired-details </Role>
<ShortName> Note 4 - PistolStar Inc. Acquisition - Finite-lived Intangible Assets Acquired (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 042 - Disclosure - Note 4 - PistolStar Inc. Acquisition - Pro Forma Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-4-pistolstar-inc-acquisition-pro-forma-information-details </Role>
<ShortName> Note 4 - PistolStar Inc. Acquisition - Pro Forma Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 043 - Disclosure - Note 5 - Accounts Receivable (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-5-accounts-receivable-details-textual </Role>
<ShortName> Note 5 - Accounts Receivable (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-5-accounts-receivable-tables </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 044 - Disclosure - Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-5-accounts-receivable-summary-of-accounts-receivable-details </Role>
<ShortName> Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 045 - Disclosure - Note 6 - Share Based Compensation - Expenses for Continuing Operations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-6-share-based-compensation-expenses-for-continuing-operations-details </Role>
<ShortName> Note 6 - Share Based Compensation - Expenses for Continuing Operations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 46 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 046 - Disclosure - Note 7 - Factoring (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-7-factoring-details-textual </Role>
<ShortName> Note 7 - Factoring (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-7-factoring-tables </ParentRole>
<Position> 47 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 047 - Disclosure - Note 7 - Factoring - Due From Factor (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-7-factoring-due-from-factor-details </Role>
<ShortName> Note 7 - Factoring - Due From Factor (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 48 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 048 - Disclosure - Note 7 - Factoring - Fees (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-7-factoring-fees-details </Role>
<ShortName> Note 7 - Factoring - Fees (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 049 - Disclosure - Note 8 - Inventory - Components of Inventory (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-8-inventory-components-of-inventory-details </Role>
<ShortName> Note 8 - Inventory - Components of Inventory (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 050 - Disclosure - Note 9 - Resalable Software License Rights (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-9-resalable-software-license-rights-details-textual </Role>
<ShortName> Note 9 - Resalable Software License Rights (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-9-resalable-software-license-rights </ParentRole>
<Position> 51 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 051 - Disclosure - Note 10 - Investment (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-10-investment-details-textual </Role>
<ShortName> Note 10 - Investment (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-10-investment </ParentRole>
<Position> 52 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 052 - Disclosure - Note 11 - Related Party Transactions (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-11-related-party-transactions-details-textual </Role>
<ShortName> Note 11 - Related Party Transactions (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-11-related-party-transactions </ParentRole>
<Position> 53 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 053 - Disclosure - Note 12 - Convertible Notes Payable (Details Textual) </LongName>
<ReportType> Notes </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable-details-textual </Role>
<ShortName> Note 12 - Convertible Notes Payable (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable-tables </ParentRole>
<Position> 54 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 054 - Disclosure - Note 12 - Convertible Notes Payable - Convertible Notes Payable (Details) </LongName>
<ReportType> Notes </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-12-convertible-notes-payable-convertible-notes-payable-details </Role>
<ShortName> Note 12 - Convertible Notes Payable - Convertible Notes Payable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 55 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 055 - Disclosure - Note 13 - Leases - Operating Lease Balance Sheet Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-13-leases-operating-lease-balance-sheet-information-details </Role>
<ShortName> Note 13 - Leases - Operating Lease Balance Sheet Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 056 - Disclosure - Note 13 - Leases - Supplemental Cash Flow Information Related to Leases (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-13-leases-supplemental-cash-flow-information-related-to-leases-details </Role>
<ShortName> Note 13 - Leases - Supplemental Cash Flow Information Related to Leases (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 57 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 057 - Disclosure - Note 13 - Leases - Operating Lease Liability Maturity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-13-leases-operating-lease-liability-maturity-details </Role>
<ShortName> Note 13 - Leases - Operating Lease Liability Maturity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 058 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") - Reconciliation of Numerator of Basic and Diluted EPS Calculations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-reconciliation-of-numerator-of-basic-and-diluted-eps-calculations-details </Role>
<ShortName> Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") - Reconciliation of Numerator of Basic and Diluted EPS Calculations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-tables </ParentRole>
<Position> 59 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 059 - Disclosure - Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") - Securities Excluded From the Diluted Per Share Calculation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-securities-excluded-from-the-diluted-per-share-calculation-details </Role>
<ShortName> Note 14 - Earnings (Loss) Per Share - Common Stock ("EPS") - Securities Excluded From the Diluted Per Share Calculation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-14-earnings-loss-per-share-common-stock-eps-tables </ParentRole>
<Position> 60 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 060 - Disclosure - Note 15 - Stockholders' Equity (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-15-stockholders-equity-details-textual </Role>
<ShortName> Note 15 - Stockholders' Equity (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-15-stockholders-equity </ParentRole>
<Position> 61 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 061 - Disclosure - Note 17 - Major Customers and Accounts Receivables (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-17-major-customers-and-accounts-receivables-details-textual </Role>
<ShortName> Note 17 - Major Customers and Accounts Receivables (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-17-major-customers-and-accounts-receivables </ParentRole>
<Position> 62 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 062 - Disclosure - Note 18 - Payment Protection Program Term Note (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-18-payment-protection-program-term-note-details-textual </Role>
<ShortName> Note 18 - Payment Protection Program Term Note (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-18-payment-protection-program-term-note </ParentRole>
<Position> 63 </Position>
</Report>
<Report instance="bkyi-20200630.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 063 - Disclosure - Note 19 - Subsequent Events (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bio-key.com/20200630/role/statement-note-19-subsequent-events-details-textual </Role>
<ShortName> Note 19 - Subsequent Events (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bio-key.com/20200630/role/statement-note-19-subsequent-events </ParentRole>
<Position> 64 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> bkyi-20200630.xml </File>
<File> bkyi-20200630.xsd </File>
<File> bkyi-20200630_cal.xml </File>
<File> bkyi-20200630_def.xml </File>
<File> bkyi-20200630_lab.xml </File>
<File> bkyi-20200630_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/us-gaap/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/country/2020-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/07/20  Bio Key International Inc.        8-K:1,2,9   6/30/20    3:371K                                   RDG Filings/FA
 7/01/20  Bio Key International Inc.        8-K:1,2,3,9 6/29/20    5:566K                                   RDG Filings/FA
 6/08/20  Bio Key International Inc.        10-Q        3/31/20   78:5.4M                                   RDG Filings/FA
↑Top
Filing Submission 0001437749-20-018059   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 2:55:41.1pm ET